Efficacy of oral voriconazole versus itraconazole in the treatment of dermatophyte infections
Phase 3
Recruiting
- Conditions
- Dermatophyte infection.Dermatophytosis
- Registration Number
- IRCT20210823052264N3
- Lead Sponsor
- PNS SHIFA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Chronic and recurrent dermatophyte infections (chronic refers to infections present for over 6 months, recurrent refers to patients with an infection in which symptoms reappear in 6 weeks after complete cure or stopping of treatment).
Exclusion Criteria
Patients with age less than 15 and greater than 90 years,
Hyperlipidemia,
Abnormal liver and renal function tests,
Pregnant and breast feeding females.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical response based on clearence of lesion and absence of fungal hyphae on KOH microscopy. Timepoint: Patients were evaluated clinically on 7th and 14th day of treatment and 4 weeks after completion of treatment. Method of measurement: Clinical evaluation.
- Secondary Outcome Measures
Name Time Method